Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Subjects

NCT01299285 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY3009104

Sponsor

Eli Lilly and Company